{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T14:30:03Z","timestamp":1747319403021,"version":"3.37.3"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s43440-023-00481-5","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T05:46:41Z","timestamp":1680500801000},"page":"544-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Potential drugs for the treatment of Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"75","author":[{"given":"Tania Guadalupe","family":"Montero-Cosme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5150-3140","authenticated-orcid":false,"given":"Luz Irene","family":"Pascual-Mathey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1617-5636","authenticated-orcid":false,"given":"Mar\u00eda Elena","family":"Hern\u00e1ndez-Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5752-4700","authenticated-orcid":false,"given":"Deissy","family":"Herrera-Covarrubias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4497-0909","authenticated-orcid":false,"given":"Fausto","family":"Rojas-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8519-5473","authenticated-orcid":false,"given":"Gonzalo Emiliano","family":"Aranda-Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,1]]},"reference":[{"issue":"F1000 Faculty R","key":"481_CR1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.12688\/f1000research.14506.1","volume":"7","author":"J Weller","year":"2018","unstructured":"Weller J, Budson A. Current understanding of Alzheimer\u2019s disease diagnosis and treatment. F1000Res. 2018;7 (F1000 Faculty Rev):1161.","journal-title":"F1000Res"},{"issue":"74","key":"481_CR2","first-page":"4338","volume":"12","author":"D Barrag\u00e1n","year":"2019","unstructured":"Barrag\u00e1n D, Parra A, Tejeiro J. Alzheimer\u2019s disease. Medicine. 2019;12(74):4338\u201346 (in Spanish).","journal-title":"Medicine"},{"issue":"4","key":"481_CR3","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s13311-019-00770-z","volume":"16","author":"PP Guan","year":"2019","unstructured":"Guan PP, Liang YY, Cao LL, Yu X, Wang P. Cyclooxygenase-2 induced the \u03b2-amyloid protein deposition and neuronal apoptosis via upregulating the synthesis of prostaglandin E2 and 15-deoxy-\u039412,14-prostaglandin J2. Neurotherapeutics. 2019;16(4):1255\u201368.","journal-title":"Neurotherapeutics"},{"key":"481_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neurobiolaging.2018.03.011","volume":"67","author":"C Wu","year":"2018","unstructured":"Wu C, Gong WG, Wang YJ, Sun JJ, Zhou H, Zhang ZJ, et al. Escitalopram alleviates stress-induced Alzheimer\u2019s disease-like tau pathologies and cognitive deficits by reducing hypothalamic-pituitary-adrenal axis reactivity and insulin\/GSK-3\u03b2 signal pathway activity. Neurobiol Aging. 2018;67:137\u201347.","journal-title":"Neurobiol Aging"},{"issue":"59","key":"481_CR5","doi-asserted-by":"publisher","first-page":"99296","DOI":"10.18632\/oncotarget.21853","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Guan PP, Yu X, Guo YS, Zhang YJ, Wang ZY, et al. COX-2 metabolic products, the prostaglandin I2 and F2\u03b1, mediate the effects of TNF-\u03b1 and Zn2+ in stimulating the phosphorylation of Tau. Oncotarget. 2017;8(59):99296\u2013311.","journal-title":"Oncotarget"},{"issue":"10","key":"481_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT. Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat Neurosci. 2020;23(10):1183\u201393.","journal-title":"Nat Neurosci"},{"issue":"11","key":"481_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2174\/1567205014666170203141717","volume":"14","author":"F Regen","year":"2017","unstructured":"Regen F, Hellmann-Regen J, Costantini E, Reale M. Neuroinflammation and Alzheimer\u2019s disease: implications for microglial activation. Curr Alzheimer Res. 2017;14(11):1140\u20138.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"481_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000369101","volume":"24","author":"S Sadigh-Eteghad","year":"2015","unstructured":"Sadigh-Eteghad S, Sabermarouf B, Majdi A, Talebi M, Farhoudi M, Mahmoudi J. Amyloid-beta: a crucial factor in Alzheimer\u2019s disease. Med Princ Pract. 2015;24(1):1\u201310.","journal-title":"Med Princ Pract"},{"issue":"1","key":"481_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1096\/fj.201800355RRRR","volume":"33","author":"PP Guan","year":"2019","unstructured":"Guan PP, Wang P. Integrated communications between cyclooxygenase-2 and Alzheimer\u2019s disease. FASEB J. 2019;33(1):13\u201333.","journal-title":"FASEB J"},{"key":"481_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154454","volume":"115","author":"Y Guo","year":"2021","unstructured":"Guo Y, Wang Q, Chen S, Xu C. Functions of amyloid precursor protein in metabolic diseases. Metabolism. 2021;115: 154454.","journal-title":"Metabolism"},{"issue":"5","key":"481_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrn.2017.29","volume":"18","author":"UC M\u00fcller","year":"2017","unstructured":"M\u00fcller UC, Deller T, Korte M. Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci. 2017;18(5):281\u201398.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"481_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/1073858419882619","volume":"26","author":"D Hefter","year":"2020","unstructured":"Hefter D, Ludewig S, Draguhn A, Korte M. Amyloid, APP, and electrical activity of the brain. Neuroscientist. 2020;26(3):231\u201351.","journal-title":"Neuroscientist"},{"issue":"11","key":"481_CR13","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/alz.12124","volume":"16","author":"RJ Caselli","year":"2020","unstructured":"Caselli RJ, Knopman DS, Bu G. An agnostic reevaluation of the amyloid cascade hypothesis of Alzheimer\u2019s disease pathogenesis: the role of APP homeostasis. Alzheimers Dement. 2020;16(11):1582\u201390.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"481_CR14","first-page":"3783","volume":"19","author":"Y Chen","year":"2019","unstructured":"Chen Y, Shi GW, Liang ZM, Sheng SY, Shi YS, Peng L, et al. Resveratrol improves cognition and decreases amyloid plaque formation in Tg6799 mice. Mol Med Rep. 2019;19(5):3783\u201390.","journal-title":"Mol Med Rep"},{"issue":"1","key":"481_CR15","first-page":"2","volume":"36","author":"AE Estrada","year":"2017","unstructured":"Estrada AE. Role of beta amyloid peptide aggregation in Alzheimer\u2019s disease. REB. 2017;36(1):2\u201311 (in Spanish).","journal-title":"REB"},{"key":"481_CR16","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine. 2019;14:5541\u201354.","journal-title":"Int J Nanomedicine"},{"issue":"12","key":"481_CR17","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019101494","volume":"38","author":"D Petit","year":"2019","unstructured":"Petit D, Hitzenberger M, Lismont S, Zoltowska KM, Ryan NS, Mercken M, et al. Extracellular interface between APP and nicastrin regulates A\u03b2 length and response to \u03b3-secretase modulators. EMBO J. 2019;38(12): e101494.","journal-title":"EMBO J"},{"issue":"1","key":"481_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2019.07.004","volume":"1862","author":"MS Wolfe","year":"2020","unstructured":"Wolfe MS. Substrate recognition and processing by \u03b3-secretase. Biochim Biophys Acta Biomembr. 2020;1862(1): 183016.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"481_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.semcdb.2020.02.006","volume":"105","author":"T Cai","year":"2020","unstructured":"Cai T, Tomita T. Structure-activity relationship of presenilin in \u03b3-secretase-mediated intramembrane cleavage. Semin Cell Dev Biol. 2020;105:102\u20139.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"481_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13041-021-00855-x","volume":"14","author":"S Kedia","year":"2021","unstructured":"Kedia S, Mandal K, Netrakanti PR, Jose M, Sisodia SS, Nair D. Nanoscale organization of nicastrin, the substrate receptor of the \u03b3-secretase complex, as independent molecular domains. Mol Brain. 2021;14(1):158.","journal-title":"Mol Brain"},{"issue":"9","key":"481_CR21","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/j.1460-9568.2009.06942.x","volume":"30","author":"L Zhong","year":"2009","unstructured":"Zhong L, Dong-hai Q, Hong-ying L, Qing-feng L. Analysis of the nicastrin promoter rs10752637 polymorphism and its association with Alzheimer\u2019s disease. Eur J Neurosci. 2009;30(9):1831\u20136.","journal-title":"Eur J Neurosci"},{"key":"481_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fmed.2019.00206","volume":"6","author":"JW Frew","year":"2019","unstructured":"Frew JW, Navrazhina K. In silico analysis of gamma-secretase-complex mutations in hidradenitis suppurativa demonstrates disease-specific substrate recognition and cleavage alterations. Front Med (Lausanne). 2019;6:206.","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"481_CR23","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1007\/s12035-020-02087-x","volume":"57","author":"DE L\u00f3pez","year":"2020","unstructured":"L\u00f3pez DE, Ballaz SJ. The Role of Brain Cyclooxygenase-2 (Cox-2) Beyond neuroinflammation: neuronal homeostasis in memory and anxiety. Mol Neurobiol. 2020;57(12):5167\u201376.","journal-title":"Mol Neurobiol"},{"issue":"11","key":"481_CR24","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.3390\/molecules26113208","volume":"26","author":"J Prabhakaran","year":"2021","unstructured":"Prabhakaran J, Molotkov A, Mintz A, Mann JJ. Progress in PET imaging of neuroinflammation targeting COX-2 enzyme. Molecules. 2021;26(11):3208.","journal-title":"Molecules"},{"issue":"10","key":"481_CR25","doi-asserted-by":"publisher","first-page":"8038","DOI":"10.1007\/s12035-018-0950-y","volume":"55","author":"R Niranjan","year":"2018","unstructured":"Niranjan R, Mishra KP, Thakur AK. Inhibition of cyclooxygenase-2 (COX-2) initiates autophagy and potentiates MPTP-induced autophagic cell death of human neuroblastoma cells, SH-SY5Y: an inside in the pathology of Parkinson\u2019s disease. Mol Neurobiol. 2018;55(10):8038\u201350.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"481_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","volume":"140","author":"SA Kent","year":"2020","unstructured":"Kent SA, Spires-Jones TL, Durrant CS. The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics. Acta Neuropathol. 2020;140(4):417\u201347.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"481_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s40478-021-01246-y","volume":"9","author":"M Robbins","year":"2021","unstructured":"Robbins M, Clayton E, Kaminski Schierle GS. Synaptic tau: a pathological or physiological phenomenon. Acta Neuropathol Commun. 2021;9(1):149.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"481_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here. Nat Rev Neurol. 2021;17(3):157\u201372.","journal-title":"Nat Rev Neurol"},{"issue":"29","key":"481_CR29","doi-asserted-by":"publisher","first-page":"24573","DOI":"10.1074\/jbc.M111.333054","volume":"287","author":"L Chami","year":"2012","unstructured":"Chami L, Buggia-Pr\u00e9vot V, Duplan E, Del Prete D, Delprete D, Chami M, et al. Nuclear factor-\u03baB regulates \u03b2APP and \u03b2- and \u03b3-secretases differently at physiological and supraphysiological A\u03b2 concentrations. J Biol Chem. 2012;287(29):24573\u201384.","journal-title":"J Biol Chem"},{"issue":"3","key":"481_CR30","first-page":"1824","volume":"19","author":"W Tong","year":"2020","unstructured":"Tong W, Chen X, Song X, Chen Y, Jia R, Zou Y, et al. Resveratrol inhibits LPS-induced inflammation through suppressing the signaling cascades of TLR4-NF-\u03baB\/MAPKs\/IRF3. Exp Ther Med. 2020;19(3):1824\u201334.","journal-title":"Exp Ther Med"},{"issue":"9","key":"481_CR31","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT. Microglia in Alzheimer\u2019s disease. J Clin Invest. 2017;127(9):3240\u20139.","journal-title":"J Clin Invest"},{"key":"481_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.semcdb.2019.05.004","volume":"94","author":"CS Subhramanyam","year":"2019","unstructured":"Subhramanyam CS, Wang C, Hu Q, Dheen ST. Microglia-mediated neuroinflammation in neurodegenerative diseases. Semin Cell Dev Biol. 2019;94:112\u201320.","journal-title":"Semin Cell Dev Biol"},{"key":"481_CR33","doi-asserted-by":"publisher","first-page":"3087475","DOI":"10.1155\/2018\/3087475","volume":"2018","author":"F Alasmari","year":"2018","unstructured":"Alasmari F, Alshammari MA, Alasmari AF, Alanazi WA, Alhazzani K. Neuroinflammatory cytokines induce amyloid beta neurotoxicity through modulating amyloid precursor protein levels\/metabolism. Biomed Res Int. 2018;2018:3087475.","journal-title":"Biomed Res Int"},{"key":"481_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.656832","volume":"15","author":"MV Chac\u00f3n-Quintero","year":"2021","unstructured":"Chac\u00f3n-Quintero MV, Pineda-L\u00f3pez LG, Villegas-Lanau CA, Posada-Duque R, Cardona-G\u00f3mez GP. Beta-secretase 1 underlies reactive astrocytes and endothelial disruption in neurodegeneration. Front Cell Neurosci. 2021;15: 656832.","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"481_CR35","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1073\/pnas.1916645117","volume":"117","author":"JH Choi","year":"2020","unstructured":"Choi JH, Han J, Theodoropoulos PC, Zhong X, Wang J, Medler D, et al. Essential requirement for nicastrin in marginal zone and B-1 B cell development. Proc Natl Acad Sci U S A. 2020;117(9):4894\u2013901.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"481_CR36","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/glia.20638","volume":"56","author":"Y Nadler","year":"2008","unstructured":"Nadler Y, Alexandrovich A, Grigoriadis N, Hartmann T, Rao KS, Shohami E, et al. Increased expression of the gamma-secretase components presenilin-1 and nicastrin in activated astrocytes and microglia following traumatic brain injury. Glia. 2008;56(5):552\u201367.","journal-title":"Glia"},{"issue":"9","key":"481_CR37","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.1007\/s12035-019-1479-4","volume":"56","author":"M Mirzaei","year":"2019","unstructured":"Mirzaei M, Pushpitha K, Deng L, Chitranshi N, Gupta V, Rajput R, et al. Upregulation of proteolytic pathways and altered protein biosynthesis underlie retinal pathology in a mouse model of Alzheimer\u2019s disease. Mol Neurobiol. 2019;56(9):6017\u201334.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"481_CR38","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jid.2019.07.702","volume":"140","author":"CH Hsu","year":"2020","unstructured":"Hsu CH, Liou GG, Jiang YJ. Nicastrin deficiency induces tyrosinase-dependent depigmentation and skin inflammation. J Invest Dermatol. 2020;140(2):404-414.e13.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"481_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12964-020-00680-0","volume":"18","author":"TH Lee","year":"2020","unstructured":"Lee TH, Liu PS, Tsai MM, Chen JL, Wang SJ, Hsieh HL. The COX-2-derived PGE2 autocrine contributes to bradykinin-induced matrix metalloproteinase-9 expression and astrocytic migration via STAT3 signaling. Cell Commun Signal. 2020;18(1):185.","journal-title":"Cell Commun Signal"},{"key":"481_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neulet.2019.04.022","volume":"705","author":"NN Naseri","year":"2019","unstructured":"Naseri NN, Wang H, Guo J, Sharma M, Luo W. The complexity of tau in Alzheimer\u2019s disease. Neurosci Lett. 2019;705:183\u201394.","journal-title":"Neurosci Lett"},{"key":"481_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejphar.2019.01.044","volume":"848","author":"E Caiazzo","year":"2019","unstructured":"Caiazzo E, Ialenti A, Cicala C. The relatively selective cyclooxygenase-2 inhibitor nimesulide: what\u2019s going on. Eur J Pharmacol. 2019;848:105\u201311.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"481_CR42","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1080\/07391102.2017.1338164","volume":"36","author":"F Azam","year":"2018","unstructured":"Azam F, Alabdullah NH, Ehmedat HM, Abulifa AR, Taban I, Upadhyayula S. NSAIDs as potential treatment option for preventing amyloid \u03b2 toxicity in Alzheimer\u2019s disease: an investigation by docking, molecular dynamics, and DFT studies. J Biomol Struct Dyn. 2018;36(8):2099\u2013117.","journal-title":"J Biomol Struct Dyn"},{"issue":"7","key":"481_CR43","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1212\/WNL.58.7.1050","volume":"58","author":"PS Aisen","year":"2002","unstructured":"Aisen PS, Schmeidler J, Pasinetti GM. Randomized pilot study of nimesulide treatment in Alzheimer\u2019s disease. Neurology. 2002;58(7):1050\u20134.","journal-title":"Neurology"},{"issue":"2","key":"481_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40266-015-0239-z","volume":"32","author":"M Miguel-\u00c1lvarez","year":"2015","unstructured":"Miguel-\u00c1lvarez M, Santos-Lozano A, Sanchis-Gomar F, Fiuza-Luces C, Pareja-Galeano H, Garatachea N, et al. Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer\u2019s disease: a systematic review and meta-analysis of treatment effect. Drugs Aging. 2015;32(2):139\u201347.","journal-title":"Drugs Aging"},{"issue":"4","key":"481_CR45","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1007\/s12035-016-9839-9","volume":"54","author":"T Ahmed","year":"2017","unstructured":"Ahmed T, Javed S, Javed S, Tariq A, \u0160amec D, Tejada S, et al. Resveratrol and Alzheimer\u2019s disease: mechanistic insights. Mol Neurobiol. 2017;54(4):2622\u201335.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"481_CR46","doi-asserted-by":"publisher","first-page":"E1122","DOI":"10.3390\/nu9101122","volume":"9","author":"Y Jia","year":"2017","unstructured":"Jia Y, Wang N, Liu X. Resveratrol and amyloid-beta: mechanistic insights. Nutrients. 2017;9(10):E1122.","journal-title":"Nutrients"},{"key":"481_CR47","doi-asserted-by":"publisher","first-page":"8152373","DOI":"10.1155\/2018\/8152373","volume":"2018","author":"BAQ Gomes","year":"2018","unstructured":"Gomes BAQ, Silva JPB, Romeiro CFR, Dos Santos SM, Rodrigues CA, Gon\u00e7alves PR, et al. Neuroprotective mechanisms of resveratrol in Alzheimer\u2019s disease: role of SIRT1. Oxid Med Cell Longev. 2018;2018:8152373.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"481_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2741\/e863","volume":"12","author":"YL Rao","year":"2020","unstructured":"Rao YL, Ganaraja B, Joy T, Pai MM, Ullal SD, Murlimanju BV. Neuroprotective effects of resveratrol in Alzheimer\u2019s disease. Front Biosci (Elite Ed). 2020;12(1):139\u201349.","journal-title":"Front Biosci (Elite Ed)"},{"issue":"1","key":"481_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0779-0","volume":"14","author":"C Moussa","year":"2017","unstructured":"Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, et al. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease. J Neuroinflammation. 2017;14(1):1.","journal-title":"J Neuroinflammation"},{"issue":"16","key":"481_CR50","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1212\/WNL.0000000000002035","volume":"85","author":"RS Turner","year":"2015","unstructured":"Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, et al. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. 2015;85(16):1383\u201391.","journal-title":"Neurology"},{"issue":"2","key":"481_CR51","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40120-021-00271-2","volume":"10","author":"J Gu","year":"2021","unstructured":"Gu J, Li Z, Chen H, Xu X, Li Y, Gui Y. Neuroprotective effect of trans-resveratrol in mild to moderate Alzheimer disease: a randomized, double-blind trial. Neurol Ther. 2021;10(2):905\u201317.","journal-title":"Neurol Ther"},{"issue":"4","key":"481_CR52","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40266-022-00923-4","volume":"39","author":"JAG Tosatti","year":"2022","unstructured":"Tosatti JAG, Fontes AFDS, Caramelli P, Gomes KB. Effects of resveratrol supplementation on the cognitive function of patients with Alzheimer\u2019s disease: a systematic review of randomized controlled trials. Drugs Aging. 2022;39(4):285\u201395.","journal-title":"Drugs Aging"},{"issue":"3","key":"481_CR53","first-page":"1625","volume":"17","author":"T Zhou","year":"2019","unstructured":"Zhou T, Wang J, Xin C, Kong L, Wang C. Effect of memantine combined with citalopram on cognition of BPSD and moderate Alzheimer\u2019s disease: a clinical trial. Exp Ther Med. 2019;17(3):1625\u201330.","journal-title":"Exp Ther Med"},{"issue":"3","key":"481_CR54","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s12035-016-9781-x","volume":"54","author":"WG Gong","year":"2017","unstructured":"Gong WG, Wang YJ, Zhou H, Li XL, Bai F, Ren QG, et al. Citalopram ameliorates synaptic plasticity deficits in different cognition-associated brain regions induced by social isolation in middle-aged rats. Mol Neurobiol. 2017;54(3):1927\u201338.","journal-title":"Mol Neurobiol"},{"key":"481_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113591","volume":"295","author":"LF Oliveira","year":"2021","unstructured":"Oliveira LF, Camargos EF, Martini LLL, Machado FV, Novaes MRCG. Use of psychotropic agents to treat agitation and aggression in Brazilian patients with Alzheimer\u2019s disease: a naturalistic and multicenter study. Psychiatry Res. 2021;295: 113591.","journal-title":"Psychiatry Res"},{"key":"481_CR56","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.neuropharm.2017.12.021","volume":"131","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Yang C, Liu T, Liu L, Li F, Cai Y, et al. Citalopram restores short-term memory deficit and non-cognitive behaviors in APP\/PS1 mice while halting the advance of Alzheimer\u2019s disease-like pathology. Neuropharmacology. 2018;131:475\u201386.","journal-title":"Neuropharmacology"},{"issue":"19","key":"481_CR57","doi-asserted-by":"publisher","first-page":"e2658","DOI":"10.1212\/WNL.0000000000010725","volume":"95","author":"YI Sheline","year":"2020","unstructured":"Sheline YI, Snider BJ, Beer JC, Seok D, Fagan AM, Suckow RF, et al. Effect of escitalopram dose and treatment duration on CSF A\u03b2 levels in healthy older adults: a controlled clinical trial. Neurology. 2020;95(19):e2658\u201365.","journal-title":"Neurology"},{"issue":"19","key":"481_CR58","doi-asserted-by":"publisher","first-page":"e2666","DOI":"10.1212\/WNL.0000000000010733","volume":"95","author":"JR Cirrito","year":"2020","unstructured":"Cirrito JR, Wallace CE, Yan P, Davis TA, Gardiner WD, Doherty BM, et al. Effect of escitalopram on A\u03b2 levels and plaque load in an Alzheimer mouse model. Neurology. 2020;95(19):e2666\u201374.","journal-title":"Neurology"},{"issue":"9","key":"481_CR59","doi-asserted-by":"publisher","first-page":"E2155","DOI":"10.3390\/molecules25092155","volume":"25","author":"N Kubick","year":"2020","unstructured":"Kubick N, Pajares M, Enache I, Manda G, Mickael ME. Repurposing zileuton as a depression drug using an AI and in vitro approach. Molecules. 2020;25(9):E2155.","journal-title":"Molecules"},{"issue":"7","key":"481_CR60","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jama.2014.93","volume":"311","author":"AP Porsteinsson","year":"2014","unstructured":"Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, et al. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 2014;311(7):682\u201391.","journal-title":"JAMA"},{"issue":"1","key":"481_CR61","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/JAD-180304","volume":"66","author":"T Nagata","year":"2018","unstructured":"Nagata T, Shinagawa S, Nakajima S, Mimura M, Shigeta M. Association between neuropsychiatric improvement and neurocognitive change in Alzheimer\u2019s disease: analysis of the CATIE-AD study. J Alzheimers Dis. 2018;66(1):139\u201348.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"481_CR62","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/bcp.12997","volume":"82","author":"T Ho","year":"2016","unstructured":"Ho T, Pollock BG, Mulsant BH, Schantz O, Devanand DP, Mintzer JE, et al. R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. Br J Clin Pharmacol. 2016;82(3):784\u201392.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"481_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1871527316666170807130011","volume":"18","author":"C Ju Hwang","year":"2019","unstructured":"Ju Hwang C, Choi DY, Park MH, Hong JT. NF-\u03baB as a key mediator of brain inflammation in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets. 2019;18(1):3\u201310.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"481_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jneuroim.2018.11.010","volume":"326","author":"BS Thawkar","year":"2019","unstructured":"Thawkar BS, Kaur G. Inhibitors of NF-\u03baB and P2X7\/NLRP3\/caspase 1 pathway in microglia: novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer\u2019s disease. J Neuroimmunol. 2019;326:62\u201374.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"481_CR65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/ADR-200171","volume":"4","author":"B Sinyor","year":"2020","unstructured":"Sinyor B, Mineo J, Ochner C. Alzheimer\u2019s disease, inflammation, and the role of antioxidants. J Alzheimers Dis Rep. 2020;4(1):175\u201383.","journal-title":"J Alzheimers Dis Rep"},{"issue":"8","key":"481_CR66","doi-asserted-by":"publisher","first-page":"E743","DOI":"10.3390\/antiox9080743","volume":"9","author":"DSA Simpson","year":"2020","unstructured":"Simpson DSA, Oliver PL. ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease. Antioxidants (Basel). 2020;9(8):E743.","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"481_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12974-021-02097-z","volume":"18","author":"JH He","year":"2021","unstructured":"He JH, Liu RP, Peng YM, Guo Q, Zhu LB, Lian YZ, et al. Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation. J Neuroinflammation. 2021;18(1):47.","journal-title":"J Neuroinflammation"},{"key":"481_CR68","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.clinbiochem.2019.04.001","volume":"72","author":"T Ozben","year":"2019","unstructured":"Ozben T, Ozben S. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer\u2019s disease. Clin Biochem. 2019;72:87\u20139.","journal-title":"Clin Biochem"},{"key":"481_CR69","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fnmol.2017.00427","volume":"10","author":"RE Gonz\u00e1lez-Reyes","year":"2017","unstructured":"Gonz\u00e1lez-Reyes RE, Nava-Mesa MO, Vargas-S\u00e1nchez K, Ariza-Salamanca D, Mora-Mu\u00f1oz L. Involvement of astrocytes in Alzheimer\u2019s disease from a neuroinflammatory and oxidative stress perspective. Front Mol Neurosci. 2017;10:427.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"481_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12035","volume":"10","author":"Z Li","year":"2020","unstructured":"Li Z, Moniruzzaman M, Dastgheyb RM, Yoo SW, Wang M, Hao H, et al. Astrocytes deliver CK1 to neurons via extracellular vesicles in response to inflammation promoting the translation and amyloidogenic processing of APP. J Extracell Vesicles. 2020;10(2): e12035.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"481_CR71","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/0028-3886.310062","volume":"69","author":"FC Gomes","year":"2021","unstructured":"Gomes FC, Mattos MF, Goloni-Bertollo EM, Pavarino \u00c9C. Alzheimer\u2019s disease in the Down syndrome: an overview of genetics and molecular aspects. Neurol India. 2021;69(1):32\u201341.","journal-title":"Neurol India"},{"key":"481_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105598","volume":"157","author":"T Zhang","year":"2021","unstructured":"Zhang T, Yu J, Wang G, Zhang R. Amyloid precursor protein binds with TNFRSF21 to induce neural inflammation in Alzheimer\u2019s disease. Eur J Pharm Sci. 2021;157: 105598.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"481_CR73","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12974-019-1663-5","volume":"16","author":"SD Shin","year":"2019","unstructured":"Shin SD, Shin A, Mayagoitia K, Siebold L, Rubini M, Wilson CG, et al. Loss of amyloid precursor protein exacerbates early inflammation in Niemann-Pick disease type C. J Neuroinflammation. 2019;16(1):269.","journal-title":"J Neuroinflammation"},{"key":"481_CR74","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3389\/fimmu.2020.01967","volume":"11","author":"P Spitzer","year":"2020","unstructured":"Spitzer P, Walter M, G\u00f6th C, Oberstein TJ, Linning P, Kn\u00f6lker HJ, et al. Pharmacological inhibition of amyloidogenic APP processing and knock-down of APP in primary human macrophages impairs the secretion of cytokines. Front Immunol. 2020;11:1967.","journal-title":"Front Immunol"},{"key":"481_CR75","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.imlet.2020.10.004","volume":"228","author":"P Millot","year":"2020","unstructured":"Millot P, San C, Bennana E, Porte B, Vignal N, Hugon J, et al. STAT3 inhibition protects against neuroinflammation and BACE1 upregulation induced by systemic inflammation. Immunol Lett. 2020;228:129\u201334.","journal-title":"Immunol Lett"},{"key":"481_CR76","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.3389\/fimmu.2018.02965","volume":"9","author":"ARJV Vossen","year":"2018","unstructured":"Vossen ARJV, van der Zee HH, Prens EP. Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model. Front Immunol. 2018;9:2965.","journal-title":"Front Immunol"},{"issue":"2","key":"481_CR77","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/bjd.18445","volume":"182","author":"T Takeichi","year":"2020","unstructured":"Takeichi T, Matsumoto T, Nomura T, Takeda M, Niwa H, Kono M, et al. A novel NCSTN missense mutation in the signal peptide domain causes hidradenitis suppurativa, which has features characteristic of an autoinflammatory keratinization disease. Br J Dermatol. 2020;182(2):491\u20133.","journal-title":"Br J Dermatol"},{"issue":"5","key":"481_CR78","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/jfbc.12594","volume":"42","author":"DAR Mukherjee","year":"2018","unstructured":"Mukherjee DAR. Resveratrol attenuates Nitrosodiethylamine-induced liver injury in anti-inflammatory manner via regulating cyclooxygenase-2. J Food Biochem. 2018;42(5):21\u20135.","journal-title":"J Food Biochem"},{"key":"481_CR79","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3389\/fphar.2020.00819","volume":"11","author":"MM Ching","year":"2020","unstructured":"Ching MM, Reader J, Fulton AM. Eicosanoids in cancer: prostaglandin E2 receptor 4 in cancer therapeutics and immunotherapy. Front Pharmacol. 2020;11:819.","journal-title":"Front Pharmacol"},{"issue":"5","key":"481_CR80","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/biolre\/ioz029","volume":"100","author":"KB Leimert","year":"2019","unstructured":"Leimert KB, Verstraeten BSE, Messer A, Nemati R, Blackadar K, Fang X, et al. Cooperative effects of sequential PGF2\u03b1 and IL-1\u03b2 on IL-6 and COX-2 expression in human myometrial cells. Biol Reprod. 2019;100(5):1370\u201385.","journal-title":"Biol Reprod"},{"issue":"7784","key":"481_CR81","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575(7784):669\u201373.","journal-title":"Nature"},{"issue":"11","key":"481_CR82","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2174\/1567205017666201130091129","volume":"17","author":"M Vaz","year":"2020","unstructured":"Vaz M, Domingues C, Trindade D, Barra C, Oliveira JM, Rosa IM, et al. IL-8 and MCP-1 Impact on tau phosphorylation and phosphatase activity. Curr Alzheimer Res. 2020;17(11):985\u20131000.","journal-title":"Curr Alzheimer Res"},{"issue":"11","key":"481_CR83","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1007\/s11064-020-03121-z","volume":"45","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhao Y, Zhang J, Yang G. Mechanisms of NLRP3 inflammasome activation: its role in the treatment of Alzheimer\u2019s disease. Neurochem Res. 2020;45(11):2560\u201372.","journal-title":"Neurochem Res"},{"issue":"3","key":"481_CR84","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3233\/JAD-181066","volume":"68","author":"LL Cao","year":"2019","unstructured":"Cao LL, Guan PP, Liang YY, Huang XS, Wang P. Cyclooxygenase-2 is essential for mediating the effects of calcium ions on stimulating phosphorylation of tau at the sites of Ser 396 and Ser 404. J Alzheimers Dis. 2019;68(3):1095\u2013111.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"481_CR85","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1515\/tjb-2020-0091","volume":"45","author":"JA Mart\u00ednez-D\u00edaz","year":"2020","unstructured":"Mart\u00ednez-D\u00edaz JA, Mar\u00eda Elena H-A, Rojas-Dur\u00e1n F, Herrera-Covarrubias D, Garc\u00eda-Hern\u00e1ndez L, Mestizo-Guti\u00e9rrez S, Aranda-Abreu G. Expression of proteins linked to Alzheimer\u2019s disease in C6 rat glioma cells under the action of lipopolysaccharide (LPS), nimesulide, resveratrol and citalopram. Turk J Biochem. 2020;45(6):793\u2013801.","journal-title":"Turk J Biochem"},{"issue":"6","key":"481_CR86","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1182\/blood-2003-04-1356","volume":"103","author":"E Andreakos","year":"2004","unstructured":"Andreakos E, Sacre SM, Smith C, Lundberg A, Kiriakidis S, Stonehouse T, et al. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal\/TIRAP. Blood. 2004;103(6):2229\u201337.","journal-title":"Blood"},{"issue":"6","key":"481_CR87","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6): a001651.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2\u20133","key":"481_CR88","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cbi.2012.08.008","volume":"200","author":"R Niranjan","year":"2012","unstructured":"Niranjan R, Rajasekar N, Nath C, Shukla R. The effect of guggulipid and nimesulide on MPTP-induced mediators of neuroinflammation in rat astrocytoma cells, C6. Chem Biol Interact. 2012;200(2\u20133):73\u201383.","journal-title":"Chem Biol Interact"},{"key":"481_CR89","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejphar.2017.05.013","volume":"810","author":"FR Temp","year":"2017","unstructured":"Temp FR, Marafiga JR, Milanesi LH, Duarte T, Rambo LM, Pillat MM, et al. Cyclooxygenase-2 inhibitors differentially attenuate pentylenetetrazol-induced seizures and increase of pro- and anti-inflammatory cytokine levels in the cerebral cortex and hippocampus of mice. Eur J Pharmacol. 2017;810:15\u201325.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"481_CR90","first-page":"55","volume":"18","author":"EC Polat","year":"2020","unstructured":"Polat EC, Bozkurt AS, Keskin Cimen F, Gulaboglu M, Altuner D. The investigation of the protective effects of nimesulide on experimental testicular ischemia-reperfusion injury in rats. Rev Int Androl. 2020;18(2):55\u201362.","journal-title":"Rev Int Androl"},{"issue":"1","key":"481_CR91","doi-asserted-by":"publisher","first-page":"10056","DOI":"10.1038\/s41598-019-46558-1","volume":"9","author":"WW Ibrahim","year":"2019","unstructured":"Ibrahim WW, Abdelkader NF, Ismail HM, Khattab MM. Escitalopram ameliorates cognitive impairment in D-galactose-injected ovariectomized rats: modulation of JNK, GSK-3\u03b2, and ERK signalling pathways. Sci Rep. 2019;9(1):10056.","journal-title":"Sci Rep"},{"key":"481_CR92","doi-asserted-by":"publisher","first-page":"2739459","DOI":"10.1155\/2020\/2739459","volume":"2020","author":"P Pic\u00f3n-Pag\u00e8s","year":"2020","unstructured":"Pic\u00f3n-Pag\u00e8s P, Guti\u00e9rrez DA, Barranco-Almohalla A, Crepin G, Tajes M, Ill-Raga G, et al. Amyloid beta-peptide increases BACE1 translation through the phosphorylation of the eukaryotic initiation factor-2\u03b1. Oxid Med Cell Longev. 2020;2020:2739459.","journal-title":"Oxid Med Cell Longev"},{"key":"481_CR93","doi-asserted-by":"publisher","first-page":"9709290","DOI":"10.1155\/2021\/9709290","volume":"2021","author":"X Wang","year":"2021","unstructured":"Wang X, Li W, Lu S, Ma Z. Modulation of the wound healing through noncoding RNA interplay and GSK-3\u03b2\/NF-\u03baB signaling interaction. Int J Genomics. 2021;2021:9709290.","journal-title":"Int J Genomics"},{"issue":"2","key":"481_CR94","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/0886022X.2014.985996","volume":"37","author":"Z Suleyman","year":"2015","unstructured":"Suleyman Z, Sener E, Kurt N, Comez M, Yapanoglu T. The effect of nimesulide on oxidative damage inflicted by ischemia-reperfusion on the rat renal tissue. Ren Fail. 2015;37(2):323\u201331.","journal-title":"Ren Fail"},{"issue":"6","key":"481_CR95","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s10753-019-01074-2","volume":"42","author":"S Su","year":"2019","unstructured":"Su S, Zhang P, Zhang Q, Yin Z. GSK-3\u03b2 inhibitor induces expression of the TLR4\/MyD88\/NF-\u03baB signaling pathway to protect against renal ischemia-reperfusion injury during rat kidney transplantation. Inflammation. 2019;42(6):2105\u201318.","journal-title":"Inflammation"},{"issue":"3","key":"481_CR96","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/md19030152","volume":"19","author":"JH Yoon","year":"2021","unstructured":"Yoon JH, Lee N, Youn K, Jo MR, Kim HR, Lee DS, et al. Dieckol ameliorates A\u03b2 production via PI3K\/Akt\/GSK-3\u03b2 regulated APP processing in SweAPP N2a cell. Mar Drugs. 2021;19(3):152.","journal-title":"Mar Drugs"},{"key":"481_CR97","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12935-020-01172-4","volume":"20","author":"X Wang","year":"2020","unstructured":"Wang X, Xu Y, Yan M, Li W, Chen J, Chen T. Effect of nicastrin on hepatocellular carcinoma proliferation and apoptosis through PI3K\/AKT signalling pathway modulation. Cancer Cell Int. 2020;20:91.","journal-title":"Cancer Cell Int"},{"key":"481_CR98","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fimmu.2020.00459","volume":"11","author":"F Qu","year":"2020","unstructured":"Qu F, Xu W, Deng Z, Xie Y, Tang J, Chen Z, et al. Fish c-Jun N-terminal kinase (JNK) pathway is involved in bacterial MDP-induced intestinal inflammation. Front Immunol. 2020;11:459.","journal-title":"Front Immunol"},{"issue":"3","key":"481_CR99","doi-asserted-by":"publisher","first-page":"E649","DOI":"10.3390\/cells9030649","volume":"9","author":"XL Shi","year":"2020","unstructured":"Shi XL, Yan N, Cui YJ, Liu ZP. A unique GSK-3\u03b2 inhibitor B10 has a direct effect on A\u03b2, targets tau and metal dyshomeostasis, and promotes neuronal neurite outgrowth. Cells. 2020;9(3):E649.","journal-title":"Cells"},{"key":"481_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.148732","volume":"794","author":"Y Ma","year":"2021","unstructured":"Ma Y, Wang J, Xu D, Chen Y, Han X. Chronic MC-LR exposure promoted A\u03b2 and p-tau accumulation via regulating Akt\/GSK-3\u03b2 signal pathway. Sci Total Environ. 2021;794: 148732.","journal-title":"Sci Total Environ"},{"issue":"2","key":"481_CR101","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/sj.mp.4001773","volume":"11","author":"W Qin","year":"2006","unstructured":"Qin W, Peng Y, Ksiezak-Reding H, Ho L, Stetka B, Lovati E, et al. Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer\u2019s disease. Mol Psychiatry. 2006;11(2):172\u201381.","journal-title":"Mol Psychiatry"},{"key":"481_CR102","doi-asserted-by":"publisher","first-page":"43154","DOI":"10.1038\/srep43154","volume":"7","author":"P Mozolewski","year":"2017","unstructured":"Mozolewski P, Moskot M, Jak\u00f3bkiewicz-Banecka J, W\u0119grzyn G, Boche\u0144ska K, Banecki B, et al. Nonsteroidal anti-inflammatory drugs modulate cellular glycosaminoglycan synthesis by affecting EGFR and PI3K signaling pathways. Sci Rep. 2017;7:43154.","journal-title":"Sci Rep"},{"issue":"17","key":"481_CR103","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.2174\/1871520620666201020160348","volume":"21","author":"M Ashrafizadeh","year":"2021","unstructured":"Ashrafizadeh M, Taeb S, Haghi-Aminjan H, Afrashi S, Moloudi K, Musa AE, et al. Resveratrol as an enhancer of apoptosis in cancer: a mechanistic review. Anticancer Agents Med Chem. 2021;21(17):2327\u201336.","journal-title":"Anticancer Agents Med Chem"},{"issue":"5","key":"481_CR104","doi-asserted-by":"publisher","first-page":"E946","DOI":"10.3390\/nu11050946","volume":"11","author":"L Malaguarnera","year":"2019","unstructured":"Malaguarnera L. Influence of resveratrol on the immune response. Nutrients. 2019;11(5):E946.","journal-title":"Nutrients"},{"key":"481_CR105","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.biocel.2017.05.015","volume":"88","author":"MH Tsai","year":"2017","unstructured":"Tsai MH, Hsu LF, Lee CW, Chiang YC, Lee MH, How JM, et al. Resveratrol inhibits urban particulate matter-induced COX-2\/PGE2 release in human fibroblast-like synoviocytes via the inhibition of activation of NADPH oxidase\/ROS\/NF-\u03baB. Int J Biochem Cell Biol. 2017;88:113\u201323.","journal-title":"Int J Biochem Cell Biol"},{"key":"481_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2017.10.002","volume":"115","author":"MC Chiang","year":"2018","unstructured":"Chiang MC, Nicol CJ, Cheng YC. Resveratrol activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress. Neurochem Int. 2018;115:1\u201310.","journal-title":"Neurochem Int"},{"key":"481_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174380","volume":"908","author":"M Omraninava","year":"2021","unstructured":"Omraninava M, Razi B, Aslani S, Imani D, Jamialahmadi T, Sahebkar A. Effect of resveratrol on inflammatory cytokines: a meta-analysis of randomized controlled trials. Eur J Pharmacol. 2021;908: 174380.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"481_CR108","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s13018-020-01944-8","volume":"15","author":"H Yi","year":"2020","unstructured":"Yi H, Zhang W, Cui ZM, Cui SY, Fan JB, Zhu XH, et al. Resveratrol alleviates the interleukin-1\u03b2-induced chondrocytes injury through the NF-\u03baB signaling pathway. J Orthop Surg Res. 2020;15(1):424.","journal-title":"J Orthop Surg Res"},{"key":"481_CR109","first-page":"9978651","volume":"2021","author":"W Li","year":"2021","unstructured":"Li W, Hu S, Chen X, Shi J. The antioxidant resveratrol protects against chondrocyte apoptosis by regulating the COX-2\/NF-\u03baB pathway in created temporomandibular osteoarthritis. Biomed Res Int. 2021;2021:9978651.","journal-title":"Biomed Res Int"},{"issue":"7","key":"481_CR110","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.sjbs.2017.05.005","volume":"25","author":"Z Yu","year":"2018","unstructured":"Yu Z, Xu W, Wang H. Resveratrol treatment inhibits acute pharyngitis in the mice model through inhibition of PGE2\/COX-2 expression. Saudi J Biol Sci. 2018;25(7):1468\u201372.","journal-title":"Saudi J Biol Sci"},{"issue":"12","key":"481_CR111","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1007\/s12011-021-03073-7","volume":"200","author":"OAR Abozaid","year":"2022","unstructured":"Abozaid OAR, Sallam MW, El-Sonbaty S, Aziza S, Emad B, Ahmed ESA. Resveratrol-selenium nanoparticles alleviate neuroinflammation and neurotoxicity in a rat model of Alzheimer\u2019s disease by regulating Sirt1\/miRNA-134\/GSK3\u03b2 expression. Biol Trace Elem Res. 2022;200(12):5104\u201314.","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"481_CR112","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12906-018-2278-6","volume":"18","author":"HT Hsu","year":"2018","unstructured":"Hsu HT, Tseng YT, Wong WJ, Liu CM, Lo YC. Resveratrol prevents nanoparticles-induced inflammation and oxidative stress via downregulation of PKC-\u03b1 and NADPH oxidase in lung epithelial A549 cells. BMC Complement Altern Med. 2018;18(1):211.","journal-title":"BMC Complement Altern Med"},{"issue":"44","key":"481_CR113","doi-asserted-by":"publisher","first-page":"9626","DOI":"10.1021\/acs.jafc.7b03252","volume":"65","author":"KA Jhang","year":"2017","unstructured":"Jhang KA, Park JS, Kim HS, Chong YH. Resveratrol ameliorates tau hyperphosphorylation at Ser396 site and oxidative damage in rat hippocampal slices exposed to vanadate: implication of ERK1\/2 and GSK-3\u03b2 signaling cascades. J Agric Food Chem. 2017;65(44):9626\u201334.","journal-title":"J Agric Food Chem"},{"issue":"2","key":"481_CR114","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11064-018-2683-8","volume":"44","author":"AA Shati","year":"2019","unstructured":"Shati AA, Alfaifi MY. Trans-resveratrol inhibits tau phosphorylation in the brains of control and cadmium chloride-treated rats by activating PP2A and PI3K\/Akt induced-inhibition of GSK3\u03b2. Neurochem Res. 2019;44(2):357\u201373.","journal-title":"Neurochem Res"},{"issue":"11","key":"481_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143345","volume":"10","author":"SY Ko","year":"2015","unstructured":"Ko SY, Ko HA, Chu KH, Shieh TM, Chi TC, Chen HI, et al. The possible mechanism of advanced glycation end products (AGEs) for Alzheimer\u2019s disease. PLoS One. 2015;10(11): e0143345.","journal-title":"PLoS One"},{"issue":"3","key":"481_CR116","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.gendis.2018.06.001","volume":"5","author":"Y Hou","year":"2018","unstructured":"Hou Y, Wang K, Wan W, Cheng Y, Pu X, Ye X. Resveratrol provides neuroprotection by regulating the JAK2\/STAT3\/PI3K\/AKT\/mTOR pathway after stroke in rats. Genes Dis. 2018;5(3):245\u201355.","journal-title":"Genes Dis"},{"issue":"24","key":"481_CR117","doi-asserted-by":"publisher","first-page":"E9575","DOI":"10.3390\/ijms21249575","volume":"21","author":"YJ Lee","year":"2020","unstructured":"Lee YJ, Kim J. Resveratrol activates natural killer cells through Akt- and mTORC2-mediated c-Myb upregulation. Int J Mol Sci. 2020;21(24):E9575.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"481_CR118","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/jnc.13173","volume":"134","author":"EH Jo","year":"2015","unstructured":"Jo EH, Ahn JS, Mo JS, Yoon JH, Ann EJ, Baek HJ, et al. Akt1 phosphorylates nicastrin to regulate its protein stability and activity. J Neurochem. 2015;134(5):799\u2013810.","journal-title":"J Neurochem"},{"issue":"10","key":"481_CR119","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/hmg\/ddab054","volume":"30","author":"AP Reddy","year":"2021","unstructured":"Reddy AP, Yin X, Sawant N, Reddy PH. Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer\u2019s disease. Hum Mol Genet. 2021;30(10):847\u201364.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"481_CR120","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41398-022-02050-5","volume":"12","author":"RJ Elsworthy","year":"2022","unstructured":"Elsworthy RJ, Crowe JA, King MC, Dunleavy C, Fisher E, Ludlam A, et al. The effect of citalopram treatment on amyloid-\u03b2 precursor protein processing and oxidative stress in human hNSC-derived neurons. Transl Psychiatry. 2022;12(1):285.","journal-title":"Transl Psychiatry"},{"key":"481_CR121","doi-asserted-by":"publisher","first-page":"1238687","DOI":"10.1155\/2017\/1238687","volume":"2017","author":"Z Wei","year":"2017","unstructured":"Wei Z, Junhong G, Xiaoyuan N, Jie W, Zhaojun W, Meina W, et al. Citalopram ameliorates impairments in spatial memory and synaptic plasticity in female 3xTgAD mice. Biomed Res Int. 2017;2017:1238687.","journal-title":"Biomed Res Int"},{"issue":"1","key":"481_CR122","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-017-0298-y","volume":"9","author":"CU von Linstow","year":"2017","unstructured":"von Linstow CU, Waider J, Grebing M, Metaxas A, Lesch KP, Finsen B. Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-\u03b2 levels in early-stage Alzheimer\u2019s-like disease in mice. Alzheimers Res Ther. 2017;9(1):74.","journal-title":"Alzheimers Res Ther"},{"key":"481_CR123","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.phrs.2018.06.015","volume":"140","author":"H Wu","year":"2019","unstructured":"Wu H, Denna TH, Storkersen JN, Gerriets VA. Beyond a neurotransmitter: the role of serotonin in inflammation and immunity. Pharmacol Res. 2019;140:100\u201314.","journal-title":"Pharmacol Res"},{"issue":"2","key":"481_CR124","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12031-014-0334-3","volume":"55","author":"D Garabadu","year":"2015","unstructured":"Garabadu D, Reddy BC, Krishnamurthy S. Citalopram protects against cold-restraint stress-induced activation of brain-derived neurotrophic factor and expression of nuclear factor kappa-light-chain-enhancer of activated B cells in rats. J Mol Neurosci. 2015;55(2):355\u201366.","journal-title":"J Mol Neurosci"},{"key":"481_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.02.015","volume":"599","author":"T Wang","year":"2022","unstructured":"Wang T, Zheng R, Sun S. Drug repurposing: escitalopram attenuates acute lung injury by inhibiting the SIK2\/ HDAC4\/ NF-\u03baB signaling cascade. Biochem Biophys Res Commun. 2022;599:1\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"481_CR126","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s13105-019-00714-3","volume":"76","author":"O Va\u0161\u00ed\u010dek","year":"2020","unstructured":"Va\u0161\u00ed\u010dek O, Lojek A, \u010c\u00ed\u017e M. Serotonin and its metabolites reduce oxidative stress in murine RAW264.7 macrophages and prevent inflammation. J Physiol Biochem. 2020;76(1):49\u201360.","journal-title":"J Physiol Biochem"},{"key":"481_CR127","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbi.2019.06.023","volume":"81","author":"C Rummel","year":"2019","unstructured":"Rummel C. Does hypothalamic serotonin govern septic inflammation via the splanchnic anti-inflammatory reflex. Brain Behav Immun. 2019;81:10\u20131.","journal-title":"Brain Behav Immun"},{"issue":"12","key":"481_CR128","first-page":"1251","volume":"29","author":"S Wang","year":"2013","unstructured":"Wang S, Chen H, Xie H. Immune regulatory effect of citalopram on microglial cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013;29(12):1251\u20133.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"4","key":"481_CR129","doi-asserted-by":"publisher","first-page":"E857","DOI":"10.3390\/cells9040857","volume":"9","author":"MB Hammouda","year":"2020","unstructured":"Hammouda MB, Ford AE, Liu Y, Zhang JY. The JNK signaling pathway in inflammatory skin disorders and cancer. Cells. 2020;9(4):E857.","journal-title":"Cells"},{"issue":"3","key":"481_CR130","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1002\/jcp.29183","volume":"235","author":"J Zheng","year":"2020","unstructured":"Zheng J, Dai Q, Han K, Hong W, Jia D, Mo Y, et al. JNK-IN-8, a c-Jun N-terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke. J Cell Physiol. 2020;235(3):2792\u20139.","journal-title":"J Cell Physiol"},{"issue":"4","key":"481_CR131","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.1096\/fj.201902230RR","volume":"34","author":"H Wu","year":"2020","unstructured":"Wu H, Wei S, Huang Y, Chen L, Wang Y, Wu X, et al. A\u03b2 monomer induces phosphorylation of tau at Ser-214 through \u03b22AR-PKA-JNK signaling pathway. FASEB J. 2020;34(4):5092\u2013105.","journal-title":"FASEB J"},{"issue":"1","key":"481_CR132","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/alz.12370","volume":"18","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Kuca K, Wu W, Wang X, Nepovimova E, Musilek K, et al. Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases. Alzheimers Dement. 2022;18(1):152\u20138.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"481_CR133","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12031-014-0475-4","volume":"56","author":"QG Ren","year":"2015","unstructured":"Ren QG, Gong WG, Wang YJ, Zhou QD, Zhang ZJ. Citalopram attenuates tau hyperphosphorylation and spatial memory deficit induced by social isolation rearing in middle-aged rats. J Mol Neurosci. 2015;56(1):145\u201353.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"481_CR134","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3233\/JAD-200401","volume":"77","author":"YJ Wang","year":"2020","unstructured":"Wang YJ, Gong WG, Ren QG, Zhang ZJ. Escitalopram alleviates Alzheimer\u2019s disease-type tau pathologies in the aged P301L tau transgenic mice. J Alzheimers Dis. 2020;77(2):807\u201319.","journal-title":"J Alzheimers Dis"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-023-00481-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-023-00481-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-023-00481-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T04:20:20Z","timestamp":1685420420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-023-00481-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":134,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["481"],"URL":"https:\/\/doi.org\/10.1007\/s43440-023-00481-5","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"type":"print","value":"1734-1140"},{"type":"electronic","value":"2299-5684"}],"subject":[],"published":{"date-parts":[[2023,4,1]]},"assertion":[{"value":"13 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}